What is the recommended prophylactic treatment for a close contact of a confirmed bacterial meningitis case?

Prophylactic Treatment for Bacterial Meningitis Exposure

Close contacts of confirmed bacterial meningitis must receive antibiotic prophylaxis immediately, with the specific regimen determined by the causative organism: ciprofloxacin 500 mg single dose for meningococcal disease (first-line), rifampicin 600 mg twice daily for 2 days as alternative, or ceftriaxone 250 mg IM single dose (preferred in pregnancy). 1, 2

Meningococcal Meningitis (N. meningitidis)

Prophylaxis is strongly indicated because close contacts face a 400-800-fold increased risk of disease, with highest risk in the first 7 days 1. This represents Level 1 evidence that prophylaxis prevents secondary cases and eradicates nasopharyngeal carriage 1.

Who Qualifies as Close Contact:

• Household members living or sleeping in same residence
• Child care center contacts
• Anyone directly exposed to oral secretions (kissing, mouth-to-mouth resuscitation, endotracheal intubation)
• University students sharing a kitchen in halls of residence 2, 3

Antibiotic Regimens (Grade A recommendation):

First-line: Ciprofloxacin 2

• Adults >16 years: 500 mg oral single dose
• Children 5-12 years: 250 mg oral single dose
• Children <5 years: 30 mg/kg (max 125 mg) oral single dose
• Contraindicated in pregnancy

Alternative: Rifampicin 1

• Adults and children >12 years: 600 mg twice daily for 2 days
• Children 3 months-12 years: 10 mg/kg twice daily for 2 days (max 600 mg)
• Children <3 months: 5 mg/kg twice daily for 2 days
• Pregnancy: 600 mg twice daily (only after first trimester)

Alternative: Ceftriaxone (preferred in pregnancy) 1

• Adults ≥16 years: 250 mg IM single dose
• Children <16 years: 125 mg IM single dose
• Pregnancy: 250 mg IM single dose (first choice)

Critical Implementation Points:

Ciprofloxacin is now preferred over rifampicin because it's single-dose, readily available in pharmacies, and avoids the risk of rifampicin-resistant isolates that can emerge during outbreak settings 2. However, emerging ciprofloxacin resistance is a concern—in areas where ≥20% of cases show ciprofloxacin resistance during a 12-month period, alternative antibiotics should be preferentially used 4.

Important caveat: Patients treated with ceftriaxone for their meningitis do NOT need additional prophylaxis, as therapeutic doses provide adequate nasopharyngeal clearance 1.

Vaccination Considerations:

• Unvaccinated contacts of vaccine-preventable serogroups (A, C, W, Y) should receive vaccination 2
• After 2 or more serogroup B cases in same household, consider MenB vaccine (Bexsero) for all household contacts 2
• Index case should receive age-appropriate meningococcal vaccination before discharge 2, 3

H. influenzae Type B Meningitis

Prophylaxis indicated only when household contains at-risk individuals (children <10 years or immunosuppressed persons of any age) 2.

Regimen:

• Rifampicin 20 mg/kg once daily for 4 days (maximum 600 mg)
• Children <3 months: 10 mg/kg once daily for 4 days
• Give to ALL household contacts AND the index case 2

Vaccination:

• All previously unvaccinated household contacts <10 years should receive Hib vaccination 2

Pneumococcal Meningitis (S. pneumoniae)

Antibiotic prophylaxis is NOT indicated for close contacts 2. Pneumococcal meningitis does not carry the same transmission risk as meningococcal disease.

Exception:

• Clusters in institutional settings (e.g., elderly care homes) should be discussed with local health protection authorities 2

Vaccination for Index Case:

• Grade B recommendation: Vaccinate the patient after recovery with pneumococcal vaccine to prevent recurrence (1-5% recurrence risk) 1
• Particularly important for patients with CSF leakage 1

Administrative Requirements

All cases must be notified to public health authorities immediately 2. The public health team (not admitting clinicians) should coordinate prophylaxis distribution 2. This ensures proper contact tracing and prevents secondary cases.

Timeline:

• Prophylaxis should be initiated as soon as possible, ideally within 24 hours of case identification
• Risk remains elevated for 6 months in contacts—general practice records should be flagged 2

Common Pitfalls to Avoid

1. Do not give prophylaxis to casual school/workplace contacts unless they meet close contact criteria 3
2. Do not use ciprofloxacin in pregnancy—use ceftriaxone instead 1
3. Do not forget the index case—they need prophylaxis too (unless treated with ceftriaxone) and vaccination 2
4. Do not delay for culture confirmation—begin prophylaxis based on clinical suspicion of meningococcal disease 2
5. Monitor for rifampicin resistance in outbreak settings—consider switching to ciprofloxacin or ceftriaxone 5